<unk>  is used to assist regulation of blood glucose level of diabetes mellitus type 2 patients. It can be used alone or in combination with metformin.<unk>  was approved by the Ministry of Food and Drug Safety (Korea) in 2013, and the postmarketing surveillance is on progress until 2019.
Lobeglitazone
Exenatide
Miglitol
Liraglutide
Insulin degludec
Linagliptin
Glimepiride
Repaglinide